Allogene Therapeutics readies for key healthcare investor conferences

Traders Union
All News
Market Voices
Allogene eyes investor talks

Top Stories

Editors' Picks

Crypto

Financial News

Currencies

Market Voices

Companies

Regulators

Central Banks

Anastasiia Chabaniuk

10.11.2025

Allogene Therapeutics readies for key healthcare investor conferences — @AllogeneTx: Allogene eyes investor talks

Allogene Therapeutics is gearing up to participate in upcoming healthcare investor conferences hosted by TD Cowen, Jefferies, and Piper Sandler.

Investors are encouraged to tune in to a fireside chat where Allogene will share insights into the future potential of its AlloCAR T products, a key area of innovation for the company. Webcasts of these events will be accessible through the Investor Relations section of their website.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

The company’s participation in these high-profile investor conferences not only spotlights its AlloCAR T portfolio but also reinforces its commitment to advancing therapies across autoimmune indications. This aligns with Allogene’s broader strategy, as seen with the recent launch of the RESOLUTION trial targeting lupus, which underscores its ongoing efforts to bring innovative solutions to complex diseases.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

Bitcoin price prediction based on RSI: Is BTC poised for a new rally?

By Oleg Tkachenko
20 hours ago

Bitcoin price prediction based on RSI: Is BTC poised for a new rally?

Editors' Picks

Toncoin becomes Gram: Why Durov restored token's original name

By Anastasiia Chabaniuk
Yesterday

Toncoin becomes Gram: Why Durov restored token's original name

Editors' Picks

Why Tether flipping Ethereum is a pivotal moment for crypto

By Kyle Torpey
15.06.2026

Why Tether flipping Ethereum is a pivotal moment for crypto

Editors' Picks

All Editors' Top Picks

Latest Allogene News

Allogene Therapeutics targets 1 in 3 LBCL relapses with ALPHA3 trial and MRD testing

By Artem Shendetskii
03.06.2026

Allogene Therapeutics targets 1 in 3 LBCL relapses with ALPHA3 trial and MRD testing

Companies

Allogene Therapeutics reviews investigational cema-cel use and early ALPHA3 safety data for community outpatients

By Eugene Komchuk
02.06.2026

Allogene Therapeutics reviews investigational cema-cel use and early ALPHA3 safety data for community outpatients

Companies

Allogene Therapeutics to present pipeline and strategy update at Jefferies Global Healthcare Conference

By Dmytro Kharkov
29.05.2026

Allogene Therapeutics to present pipeline and strategy update at Jefferies Global Healthcare Conference

Companies

All Allogene News

Oleg Tkachenko
20 hours ago

Bitcoin price prediction based on RSI: Is BTC poised for a new rally?

Anastasiia Chabaniuk
Yesterday

Toncoin becomes Gram: Why Durov restored token's original name

Kyle Torpey
15.06.2026

Why Tether flipping Ethereum is a pivotal moment for crypto

Eugene Komchuk
15.06.2026

MiCA deadline: Why crypto companies are leaving Europe

Mikhail Vnuchkov
13.06.2026

From “Holy Trinity” to WLD crash: How Arthur Hayes became a market-moving seller

Jose Antonio Gastelum
8 min ago

STRC falls 10 percent as investors expect stability, Caleb Franzen notes

Yulia Slavina
23 min ago

John Cochrane: Wealth transfers may convert capital to consumption and harm economy

Igor Krasulya
43 min ago

Markets may trigger unprecedented money printing, Quinten Francois warns

Olga Shendetskaya
1 hour ago

Modeling risk with algorithms for finance, Kirk Borne notes

Yaroslav Dmytrenko
1 hour ago

Scott Melker: Fidelity launches digital fund to manage stablecoin reserves for institutions

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Andrey Mastykin
14 hours ago

Fed expected to hold rates at Warsh first meeting

Fed expected to hold rates at Warsh first meeting

Andrey Mastykin
17 hours ago

IEA warns of weaker oil demand and supply surplus by 2027

IEA warns of weaker oil demand and supply surplus by 2027

Eugene Komchuk
18 hours ago

Traders Union research: 58% of crypto investors have encountered scams

Traders Union research: 58% of crypto investors have encountered scams

Parshwa Turakhiya
20 hours ago

Sam Bankman-Fried weighs token launch after prison sentence

Sam Bankman-Fried weighs token launch after prison sentence

Ivan Andriyenko
21 hours ago

U.S. futures rise before Fed rate decision

U.S. futures rise before Fed rate decision

Top 5 companies for you

United States

Live News

Mykhailo Ihnatenko
Now

FDA boost lifts Moderna shares: Can MRNA extend rally?

Anton Kharitonov
Now

Alphabet maintains uptrend as key resistance test approaches

Mykhailo Ihnatenko
Now

SpaceX and robotaxis put Tesla under pressure

Anton Kharitonov
Now

Microsoft holds above major support as long-term uptrend remains intact

Mykhailo Ihnatenko
Now

AMD rallies on AI growth as insider selling raises concerns

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.